119 related articles for article (PubMed ID: 1132819)
1. [Liver damage following salicylate intake].
Bar-Meir S; Papa MZ
Harefuah; 1975 Mar; 88(5):241. PubMed ID: 1132819
[No Abstract] [Full Text] [Related]
2. Salicylate hepatitis.
O'Gorman T; Koff RS
Gastroenterology; 1977 Apr; 72(4 Pt 1):726-8. PubMed ID: 838229
[TBL] [Abstract][Full Text] [Related]
3. [Salicylate hepatitis].
O'Gorman T; Koff RS
Wien Med Wochenschr; 1978 Jul; 128(14):434. PubMed ID: 706392
[No Abstract] [Full Text] [Related]
4. Letter: Salicylate hepatotoxicity and HL-A-W27.
Schulman P
Ann Intern Med; 1976 Jun; 84(6):754-5. PubMed ID: 937899
[No Abstract] [Full Text] [Related]
5. Salicylate hepatitis in a case of juvenile dermatomyositis.
Lahaie RG; Blondin C; Huet PM
Can Med Assoc J; 1979 Jun; 120(11):1399-400. PubMed ID: 455188
[No Abstract] [Full Text] [Related]
6. Salicylate-induced hepatotoxicity: a review.
Bryant CE
J Okla State Med Assoc; 1978 Jul; 71(7):284-7. PubMed ID: 671139
[No Abstract] [Full Text] [Related]
7. Letter: Salicylate toxicity.
Prinsloo JG
S Afr Med J; 1974 Dec; 48(61):2540. PubMed ID: 4453933
[No Abstract] [Full Text] [Related]
8. Salicylate hepatotoxicity: the potential role of hypoalbuminemia.
Gitlin N
J Clin Gastroenterol; 1980 Sep; 2(3):281-5. PubMed ID: 7451927
[TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity of salicylates in monolayer cell cultures.
Tolman KG; Peterson P; Gray P; Hammar SP
Gastroenterology; 1978 Feb; 74(2 Pt 1):205-8. PubMed ID: 620893
[TBL] [Abstract][Full Text] [Related]
10. Toxic encephalopathy with hyperammonaemia during high-dose salicylate therapy.
Mäkelä AL; Lang H; Korpela P
Acta Neurol Scand; 1980 Mar; 61(3):146-56. PubMed ID: 7395459
[TBL] [Abstract][Full Text] [Related]
11. Analgesic hepatotoxicity.
Babb RR
West J Med; 1978 Aug; 129(2):164-5. PubMed ID: 695571
[No Abstract] [Full Text] [Related]
12. Salicylate hepatotoxicity in rheumatoid arthritis.
Mastaglia GL
Med J Aust; 1980 Sep; 2(6):341. PubMed ID: 7421712
[No Abstract] [Full Text] [Related]
13. Acute liver failure and encephalopathy (Reye's syndrome?) during salicylate therapy.
Daum F; Zucker P; Cohen MI
Acta Paediatr Scand; 1976 Nov; 65(6):747. PubMed ID: 998231
[No Abstract] [Full Text] [Related]
14. Raised serum transaminase levels in patients with rheumatic fever treated with salicylates.
Gitlin N; Grant J
S Afr Med J; 1977 May; 51(20):697-8. PubMed ID: 877782
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic hepatitis after ingestion of choline magnesium trisalicylate.
Nadkarni MM; Peller CA; Retig J
Am J Gastroenterol; 1992 Jan; 87(1):151-3. PubMed ID: 1728115
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis caused by diflunisal (Dolobis). Apropos of a case].
Geoffroy P; Carteret E; Salagnac V; Kalis B; Zeitoun P
Therapie; 1987; 42(2):253. PubMed ID: 3617008
[No Abstract] [Full Text] [Related]
17. Hepatotoxicity associated with choline magnesium trisalicylate: case report and review of salicylate-induced hepatotoxicity.
Cersosimo RJ; Matthews SJ
Drug Intell Clin Pharm; 1987; 21(7-8):621-5. PubMed ID: 3301251
[TBL] [Abstract][Full Text] [Related]
18. Salicylate induced hepatotoxicity in juvenile rheumatoid arthritis--a case report.
Rochanawutanon M; Bunyaratvej S; Israngkura P
J Med Assoc Thai; 1979 Nov; 62(11):646-51. PubMed ID: 512520
[No Abstract] [Full Text] [Related]
19. Prevalence of liver disease in patients taking salicylates for arthropathy.
Carneskog J; Florath-Ahlmen M; Olsson R
Hepatogastroenterology; 1980 Oct; 27(5):361-4. PubMed ID: 7203370
[TBL] [Abstract][Full Text] [Related]
20. [Drug-induced chronic aggressive hepatitis].
Rotermund HM
Med Klin; 1977 Dec; 72(50):2139-45. PubMed ID: 593197
[No Abstract] [Full Text] [Related]
[Next] [New Search]
